Kura Oncology reports positive long-term cancer drug trial data Jun 11, 2026 08:03AM
UBS Downgrades Kirin Holdings Co Ltd (2503:JP) (KNBWY) to Neutral Apr 23, 2026 02:47AM
Kura Oncology (KURA) and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association Congress Jun 12, 2025 07:31AM
Kura Oncology (KURA) and Kyowa Kirin Announce FDA Acceptance and Priority Review of New Drug Application for Ziftomenib Jun 1, 2025 07:14PM
Kura Oncology (KURA) and Kyowa Kirin announce abstract on ziftomenib trial May 22, 2025 05:36PM


Apr 8, 2025 07:30AM Kura Oncology (KURA) and Kyowa Kirin Announce Submission of New Drug Application for Ziftomenib to FDA
Jan 27, 2025 11:29AM Kirin Holdings Co Ltd (2503:JP) (KNBWY) PT Raised to JPY2,250 at Morgan Stanley
Jan 20, 2025 07:02AM JPMorgan Starts Kirin Holdings Co Ltd (2503:JP) (KNBWY) at Neutral
Dec 9, 2024 07:05AM Kura Oncology (KURA) and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting